AMPK promotes osteogenesis and inhibits adipogenesis through AMPK-Gfi1-OPN axis

Y Wang, X Qu, Y Yang, X Han, L Wang, H Qiao, Q Fan… - Cellular signalling, 2016 - Elsevier
Y Wang, X Qu, Y Yang, X Han, L Wang, H Qiao, Q Fan, T Tang, K Dai
Cellular signalling, 2016Elsevier
Several metabolic, genetic and oncogenic bone diseases share the common pathological
phenotype of defective bone marrow stromal cell (BMSC) differentiation. Many reports in
bone science in the past several years have suggested that the skeleton also has an
endocrine role. The role of AMP-activated protein kinase (AMPK) as an energy metabolism
sensor and how it regulates BMSC differentiation is largely unknown. In the current study,
we used AMPK agonists to activate AMPK in MC3T3-E1 cells to investigate the functional …
Abstract
Several metabolic, genetic and oncogenic bone diseases share the common pathological phenotype of defective bone marrow stromal cell (BMSC) differentiation. Many reports in bone science in the past several years have suggested that the skeleton also has an endocrine role. The role of AMP-activated protein kinase (AMPK) as an energy metabolism sensor and how it regulates BMSC differentiation is largely unknown. In the current study, we used AMPK agonists to activate AMPK in MC3T3-E1 cells to investigate the functional roles of AMPK in osteogenesis. However, metformin and AICAR failed to activate AMPK consistently. Therefore, we established MC3T3-E1 and 3T3-L1 cell models of AMPK α subunit overexpression through lentivirus vector, in which AMPK was overactivated. AMPK hyperactivation stimulated MC3T3-E1 cell osteogenesis and inhibited 3T3-L1 cell adipogenesis. Osteopontin (OPN) mediated AMPK regulation of osteogenesis and adipogenesis. Furthermore, we provided evidence that the transcriptional repressor growth factor independence-1 (Gfi1) was downregulated and disassociated from the OPN promoter in response to AMPK activation, resulting in the upregulation of OPN. Overexpression of wild-type and dominant-negative Gfi1 modulated MC3T3-E1 osteogenesis and 3T3-L1 adipogenesis. Further evidence suggested that AMPK enhanced ectopic bone formation of MC3T3-E1 cells through the AMPK-Gfi1-OPN axis. In conclusion, AMPK was sufficient to stimulate osteogenesis of MC3T3-E1 cells and inhibit adipogenesis of 3T3-L1 cells through the AMPK-Gfi1-OPN axis. These findings helped elucidate the molecular mechanisms underlying AMPK regulation of osteogenesis and adipogenesis.
Elsevier